medline.ch Onkologie Gynäkologische Tumoren

medline.ch

tellmed.ch

En | De

Impressum | Feedback

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Onkologie » Gynäkologische Tumoren

22. Mai 2012

Kardiovaskuläre Erkrankungen

Muskuloskelettale Erkrankungen

Gynäkologische Tumoren

Schrift:

Seite 1 von 7025


	Artikel 1 - 20 / 140485

	Ovarian Cancer and Body Size: Individual Participant Meta-Analysis Including 25,157 Women with Ovarian Cancer from 47 Epidemiological Studies. PLoS Med. Collaborative Group on Epidemiological Studies of Ovarian Cancer. PMID: 22606070 [PubMed - as supplied by publisher]
	PET-CT aids in the diagnosis of a choroidal mass with retinal detachment in a patient with history of breast cancer and sarcoidosis. BMJ Case Rep. Davison JM, Hotchkiss JH, Fadell AJ, Graham JA. PMID: 22605712 [PubMed - in process]
	Long-term incidence of breast cancer by trial arm in one county of the Swedish Two-County Trial of mammographic screening. Cancer. Yen AM, Duffy SW, Chen TH, Chen LS, Chiu SY, Fann JC, Wu WY, Su CW, Smith RA, Tabár L. PMID: 22605639 [PubMed - as supplied by publisher]
	Histological confirmation of breast cancer registration and self-reporting in England and Wales: a cohort study within the UK Collaborative Trial of Ovarian Cancer Screening. Br J Cancer. Fourkala EO, Gentry-Maharaj A, Burnell M, Ryan A, Manchanda R, Dawnay A, Jacobs I, Widschwendter M, Menon U. PMID: 22596242 [PubMed - as supplied by publisher]
	Immunohistochemistry Applied to the Differential Diagnosis Between Ductal and Lobular Carcinoma of the Breast. Appl Immunohistochem Mol Morphol. de Deus Moura R, Wludarski SC, Carvalho FM, Bacchi CE. PMID: 22595945 [PubMed - as supplied by publisher]
	Evolving concepts in the management of drug resistant ovarian cancer: Dose dense chemotherapy and the reversal of clinical platinum resistance. Cancer Treat Rev. Pinato DJ, Graham J, Gabra H, Sharma R. PMID: 22595680 [PubMed - as supplied by publisher]
	Predictive role of post-treatment [(18)F]FDG PET/CT in patients with uterine cervical cancer. Eur J Radiol. Hoon Chung H, Kim JW, Kang KW, Park NH, Song YS, Chung JK, Kang SB. PMID: 22595504 [PubMed - as supplied by publisher]
	Comprehensive geriatric assessment for older women with early breast cancer - a systematic review of literature. World J Surg Oncol. Parks RM, Lakshmanan R, Winterbottom L, Morgan DA, Cox K, Cheung KL. PMID: 22594557 [PubMed - as supplied by publisher]
	A Retrospective In Vitro Study of the Impact of Anti-diabetics and Cardioselective Pharmaceuticals on Breast Cancer. Anticancer Res. Szewczyk M, Richter C, Briese V, Richter DU. PMID: 22593501 [PubMed - in process]
	Lipid Profiles and Risk of Breast and Ovarian Cancer in the Swedish AMORIS Study. Cancer Epidemiol Biomarkers Prev. Melvin JC, Seth D, Holmberg L, Garmo H, Hammar N, Jungner I, Walldius G, Lambe M, Wigertz A, Van Hemelrijck M. PMID: 22593241 [PubMed - as supplied by publisher]
	Who participates in a randomized trial of mindfulness-based stress reduction (MBSR) after breast cancer? A study of factors associated with enrollment among Danish breast cancer patients. Psychooncology. Würtzen H, Dalton SO, Andersen KK, Elsass P, Flyger HL, Sumbundu A, Johansen C. PMID: 22592966 [PubMed - as supplied by publisher]
	Scapula alata in early breast cancer patients enrolled in a randomized clinical trial of post-surgery short-course image guided radiotherapy. World J Surg Oncol. Adriaenssens N, De Ridder M, Lievens P, Van Parijs H, Vanhoeij M, Miedema G, Voordeckers M, Versmessen H, Storme G, Lamote J, Pauwels S, Vinh-Hung V. PMID: 22591589 [PubMed - as supplied by publisher]
	Multiple VEGF Family Members are Simultaneously Expressed in Ovarian Cancer: a Proposed Model for Bevacizumab Resistance. Curr Pharm Des. van der Bilta AR, van der Zee AG, de Vries EG, de Jong S, Timmer-Bosscha H, Ten Hoor KA, den Dunnen WF, Hollema H, Reyners AK. PMID: 22591424 [PubMed - as supplied by publisher]
	Survival benefit of adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the different time-points of treatment of ovarian cancer: review of evidence. Curr Pharm Des. Mulier S, Claes JP, Dierieck V, Amiel JO, Pahaut JP, Marcelis L, Bastin F, Vanderbeeken D, Finet C, Cran S, Velu T. PMID: 22591422 [PubMed - as supplied by publisher]
	The role of bevacizumab in advanced epithelial ovarian cancer. Curr Pharm Des. Kroep JR, Nortier JW. PMID: 22591420 [PubMed - as supplied by publisher]
	Role of Farletuzumab in Epithelial Ovarian Carcinoma. Curr Pharm Des. Jelovac D, Armstrong DK. PMID: 22591419 [PubMed - as supplied by publisher]
	Disparities in late stage diagnosis, treatment, and breast cancer-related death by race, age, and rural residence among women in georgia. Women Health. Markossian TW, Hines RB. PMID: 22591230 [PubMed - in process]
	The Association Between Dietary Lignans, Phytoestrogen-Rich Foods, and Fiber Intake and Postmenopausal Breast Cancer Risk: A German Case-Control Study. Nutr Cancer. Zaineddin AK, Buck K, Vrieling A, Heinz J, Flesch-Janys D, Linseisen J, Chang-Claude J. PMID: 22591208 [PubMed - as supplied by publisher]
	Integrated analysis of gene expression and tumor nuclear image profiles associated with chemotherapy response in serous ovarian carcinoma. PLoS One. Liu Y, Sun Y, Broaddus R, Liu J, Sood AK, Shmulevich I, Zhang W. PMID: 22590536 [PubMed - in process]
	Improving survival and limiting toxicity: latest advances in treating human epidermal growth factor receptor 2 overexpressing breast cancer. Ther Adv Med Oncol. Abramson VG, Mayer IA. PMID: 22590487 [PubMed - in process]

Artikel 1 - 20 / 140485

Seite 1 von 7025

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch Tel: +41 (0)44 204 16 77 Fax: +41(0)44 204 16 70
	Disclaimer \| Privacy Policy